Ads
related to: carboplatin chemotherapy- Treatment For BTCs
Is A Treatment An Option For
Your Patients With BTCs? View Study
- Dosing & Administration
View Dosing Regimen For A
Therapy For Biliary Tract Cancers.
- Discover The Data
See Efficacy & Safety Data For A
Treatment For Biliary Tract Cancers
- Clinical Study About BTCs
See Trial Data For A Therapy
For Biliary Tract Cancers.
- Resources & Support
Access Educational Resources &
Support For A Treatment For BTCs.
- Request A Representative
Have Questions? Connect With A Rep
To Get The Answers You Need.
- Treatment For BTCs
Search results
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 4 days agoCompared to the chemotherapy control, ivonescimab plus...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 6 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 1 day agoPatients in the trial received 80mg of Tagrisso once daily, along with pemetrexed and a choice of...
Perioperative Chemo Extends Survival in Resectable Esophageal Cancer
MedPage Today· 3 days agoOS rates in the two treatment arms, respectively, were 57.4% and 50.7% at 3 years, and 50.6% and...
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
MedPage Today· 5 days agoChina-based trial may present a hurdle to FDA approval, however
Cullinan Therapeutics announces success for zipalertinib as combo therapy
Clinical Trials Arena via Yahoo Finance· 2 days agoEGFR is overexpressed in tumour cells and involved in cell proliferation. Johnson & Johnson’s...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 2 days agoThe therapy was evaluated as a monotherapy and in combination with AbbVie’s investigative programmed...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
telegraphherald.com· 5 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 7 days agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Valley City Times Record· 2 days agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line treatment in patients with advanced ...
Ads
related to: carboplatin chemotherapy